serotype specificity. Mittal et al. (1988) suggested that their localization is in cell-wall components and described quantification of the type and groupspecific antigens for differentiation of serotype 3, 6 and 8 by quantitative coagglutination test. Mittal et al. (1993b) also used quantitative coagglutination test for identification of isolates with cross-reactivity between serotypes 1, 9, and 11. Although, monoclonal antibodies targeted to specific epitopes were considered to be more precise for serological classification (Lacouture et al., 1997) , production and characterization of specific monoclonal antibodies for serotypes 9 and 11 has not yet been reported.
Because of serological cross-reactions, alternative methods for precise identification of individual serotypes were also tested. Individual serotypes have been distinguished into five groups on the basis of production the Apx exotoxins or on the gene-toxin profile (Frey et al., 1993; Beck et al., 1994) . A PCR identification system of A. pleuropneumoiae has been proposed on the basis of presence or absence of apx genes in the genome of individual serotypes (Frey et al., 1995; Gram et al., 2000) . The ApxIVA gene presented in all A. pleuropneumoniae serotypes has also been used in discrimination of A. pleuropneumoniae by PCR-REA technique (Jaglic et al., 2004) . The omlA gene has also been shown as a suitable target for molecular typing by PCR or PCR-REA (Gram et al., 2000; Cho and Chae, 2003) .
Porcine pleuropneumonia is a respiratory disease resulting in high morbidity and mortality of pigs and accordingly economic losses within the swine industry worldwide, including the Czech Republic. Determination of the distribution of A. pleuropneumoniae serotypes is essential in the control, therapeutic or immunoprophylactic programmes, in order to facilitate elimination of the disease. Therefore the objective of our study was determination of the serotype distribution of A. pleuropneumoniae from lung tissues of pigs which died from porcine pleuropneumonia in the Czech Republic during the period 2003-2004. 
MATERIAL AND METHODS

Bacterial strains and culture media
Twelve reference strains of A. pleuropneumoniae (strains 4074, S1536, S1421, M62, K17, Femo, WF83, 405, CVJ13261, D13039, 56153, 8329, serotypes 1-12, respectively) were selected for the preparation of hyperimmune rabbit sera or were used as positive control for serotyping and molecular typing.
A total of 254 isolates of A. pleuropneumoniae have been included in this study. These strains originated from 52 farms located in the Czech Republic and were isolated from pathological lesions in pulmonary tissues of pigs which died from porcine pleuropneumonia in 2003-2004. The lung tissues were inoculated onto blood agar plates (Blood Agar Base No.2, HiMedia, India) with a streak of Staphylococcus aureus for production of NAD. The isolates were incubated at 37°C for 18 h. After another passage through PPLO agar (PPLO Agar Base, HiMedia, India) supplemented with NAD, the cultures were suspended in phosphate buffered saline solution (PBS) of pH 7.2 and bovine fetal serum and stored at -70°C until used.
Preparation of hyperimmune sera
New Zealand white rabbits were inoculated with formalinized whole cell suspensions of the reference strains. Antigen preparation and immunization were performed as described by Mittal et al. (1982) . Sera were stored at -20°C until used.
Coagglutination (CoA) test
The preparation of coagglutination reagents, processing and evaluation were described earlier in details by Mittal et al. (1983) . Whole -cell suspensions were prepared according to the method of Mittal et al. (1993b) with slight modifications. Bacterial cultures were harvested in PBS containing 0.3% formalin and then adjusted to an optical density (OD) of 0.5 at 550 nm. The specificity of the CoA technique was verified using antigens of the reference strains. Cell suspension of Staphylococcus aureus Cowan I (CCM 2352) in PBS and in normal rabbit serum without antibodies to A. pleuropneumoniae was used as negative controls.
Quantitative coagglutination (QCoA) test
Preparation of absorbed hyperimmune sera, as well as the procedure and evaluation of the test were carried out according to Mittal et al. (1993b) with small modifications. Bacterial culture was harvested in PBS containing 0.3% formalin, adjusted to OD 1 at 550 nm, and the antigen was further two-fold diluted in PBS from 1 : 5 to 1 : 80. Negative controls were used as described in CoA.
PCR identification of apx and omlA genes
A loopful of a bacterial colony was resuspended in 100 µl of deionized water, boiled for 10-15 min and centrifuged at 10 000 g for 10 min. The supernatant was used for the PCR reaction. Preparation of the reaction mixture, PCR, detection and visualization of the amplification products were performed according to the procedure by Gram et al. (2000) . DNA obtained from the reference strains A. pleuropneumoniae was used as a positive control; deionized water was used as a negative control.
RESULTS AND DISCUSSION
Serotyping of the isolates by CoA revealed high percentage of cross-reactions between serotypes 9 and 11 (54.7%) or 1, 9, and 11 (8.7%). In total, 11.0% of the isolates were non-typable by CoA (Table 1) . By non-typable isolates we understand isolates that react with none or with two or more of the coagglutination reagents for A. pleuropneumoniae serotypes 1 to 12, but exclude those isolates that showed cross-reactivity with coagglutination reagents for serotypes 9 and 11 or 1, 9, and 11. Cross-reactivity observed between the serotypes 1, 9, and 11 is most likely associated with the presence of common immunodominant epitopes located on the O antigen of LPS (Barbosa et al., 1996) .
The sensitivity of QCoA for differentiation of serotypes 1, 9, and 11 was tested using the reference strains A. pleuropneumoniae of serotypes 1, 9, and 11 ( Table 2 ). The antigens of the serotypes 1 and 9 showed reactivity with homologous coagglutination reagents but showed no reactivity with heterologous coagglutination reagents. Antigen of the serotype 11 reacted with a homologous coag- a isolates with cross-reactivity b isolates with cross-reactivity c non-typable isolates that react with none or with two or more of the coagglutination reagents for A. pleuropneumoniae serotypes 1 to 12, but exclude those isolates that showed cross-reactivity with coagglutination reagents for serotypes 9 and 11 or 1, 9, and 11 WC formalinised whole-cell suspension glutination reagent at titre 40 and heterologous coagglutination reagent for serotype 9 at titre 5. The results obtained confirm the ability of QCoA to differentiate between the references strains of serotype 1, 9, and 11 by determining the titres of antigens following reaction with homologous and heterologous coagglutination reagents. The isolates showing cross-reactivity between serotypes 9 and 11 (139 isolates) or 1, 9, and 11 (22 isolates) examined by CoA were more precisely tested by QCoA. Determination of the titres of antigens resulted in classification of 118 isolates into serotype 9 and 24 isolates into serotype 11. Identical titres of antigen to coagglutination reagents for serotype 9 and 11 were detected in only 19 isolates which were classified as isolates with cross-reactivity between serotypes 9 and 11 (Table 3 ). The isolates classified by QCoA into the serotype 9 or 11 either did not react with the heterologous coagglutination reagent or reacted only with a concentrated antigen or at antigen dilution of 1 : 5. At higher dilutions of antigen, cross-reactions were eliminated while positive reactions with homologous coagglutination reagents could be seen. The results obtained are consistent with the fact that strains of serotype 9 and 11 may also be antigenically diverse and show a varying degree of cross-reactivity with polyclonal rabbit sera (Mittal et al., 1993b) .
Twenty eight isolates which were finally signed as non-typable in the CoA test has not been further serotyped by the QCoA for specific differential susceptibility of this test used in our study. These isolates were classified by PCR according to Gram et al. (2000) into the apx/omlA pattern 1 (serotype 1, 9, and 11; 19 isolates), pattern 2 (serotypes 2, 8; 6 isolates) and pattern 7 (serotypes 7, 13; 3 isolates) ( Table 4 ). A precise serotype determination of isolates belonging to the highly virulent apx/omlA of pattern 1 has been problematic also using genetic methods (in particular the serotypes 9 and 11). Two studies reported on successful differentiation of these two serotypes. Hennessy et al. (1993) used arbitrarily primed PCR to distinguish these two serotypes and de la Puente-Redondo et al. (2000) reported on variability of tbpA gene in serotypes 9 and 11. However, arbitrarily primed PCR is known to be quite difficult to standardise (Black, 1993) and concerning the tbpA gene variability, we previously amplified the gene sequence and digested the PCR product with restriction endonuclease AsnI exactly as described (de la Puente-Redondo et al., 2000) .
By combining the results from CoA and QCoA, the serotype distribution among the Czech isolates could be determined. Serotype 9 was found to have the highest prevalence (46.5%) followed by serotype 2 (18.5%), 11 (14.2%), and isolates showing two-way cross-reaction between serotypes 9 and 11 (7.5%). The occurrence of other serotypes (4, 5, 7 and 12) was sporadic (in a total 2.4%). Serologically nontypable isolates were examined by PCR and classified as serotypes 1, 9, 11 (7.5%); 2, 8 (2.3%) and 7, 13, (1.1%).
The results suggest that there has been a change in the serotype distribution in the Czech Republic. Skollova and Gois (1987) found that serotype 2 had the highest prevalence, while Satran and Nedbalcova (2002) reported that serotype 9 had the highest frequency followed by serotype 2. The results of serotyping in our study showed that serotype 9 was dominant followed by serotypes 2 and 11. We also found an increased frequency of serotype 11 (from 4.1% to 14.2%) compared to the previous study by Satran and Nedbalcova (2002) . Only a single isolate was fund of serotype 5, a strongly virulent serotype, which is dominant in Canada, in the USA and Italy (Dubreuil, 2000) . Distribution of A. pleuropneumoniae serotypes determined in our study differ from the dominant serotypes reported by Dubreuil et al. (2000) in other European countries (serotypes 2 in Denmark, Sweden, Norway and Switzerland; 2, 3 and 8 in the United Kingdom; 9 in France; 2, 7 and 9 in Germany; 2, 3 and 7 in Hungary; 3 in Ireland and Belgium; 2, 9 and 11 in the Netherlands; 1 and 9 in Poland; 2, 4 and 7 in Spain; 2 and 9 in Croatia). This indicates that there is a risk of introducing new serological varieties of A. pleuropneumoniae by purchasing pigs from regions with other distribution of serotypes.
